Tag: regulatory strategy
-

Insmed to Present at the 44th Annual JP Morgan Healthcare Conference: What Investors Should Expect
Insmed to Present at the 44th Annual JP Morgan Healthcare Conference Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company, announced its plan to present at the 44th Annual JP Morgan Healthcare Conference. The conference, widely considered a bellwether event for the biopharma sector, will gather investors, analysts, and industry leaders to hear the latest…
